Company news
Bone Biologics Corp news in 2026
Bone Biologics Corp's news releases, calls and decks from 2026, newest first.
Bone Biologics Expands Trial Sites
September 8, 2026
Bone Biologics to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
September 3, 2026
Bone Biologics Achieves 32-Month Validated Shelf Life for rhNELL-1
August 12, 2026
Bone Biologics Issues Mid-Year Shareholder Update Highlighting Progress Across 2026 Priorities
July 23, 2026
Bone Biologics Announces up to $9.0 Million Private Placement Priced At-The-Market Under Nasdaq Rules
July 6, 2026
Bone Biologics Achieves 29-Month Validated Shelf Life for rhNELL-1
May 18, 2026
Bone Biologics Highlights 2025 Key Operational, Scientific, and Corporate Milestones and Provides 2026 Outlook
January 8, 2026
Decks in 2026
- Investor Presentation (August 2026)
Investor deck · 17 slides · August 2026